HCW Biologics Inc. (HCWB) Earnings History
Net Loss7 years of earnings data (2019–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
HCW Biologics Inc. (HCWB) Earnings Overview
As of June 22, 2026, HCW Biologics Inc. (HCWB) reported trailing twelve-month net income of -$2M, reflecting -1280.5% year-over-year growth. The company earned $-0.78 per diluted share over the past four quarters, with a net profit margin of -14677.1%.
Looking at the long-term picture, HCWB's historical earnings data spans multiple years. The company achieved its highest annual net income of -$6M in fiscal 2020.
HCW Biologics Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including IMVT (-$506M net income), ARQT (-$2M net income, -4.3% margin), KYMR (-$315M net income, -794.4% margin), HCWB has comparable earnings metrics. Compare HCWB vs IMVT →
HCWB Earnings vs Peers
Earnings metrics vs comparable public companies
HCWB Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$8M | +73.5% | -$11M | $-10.63 | -14677.1% | -20757.6% |
| 2024 | -$30M | -20.1% | -$29M | $-0.77 | -1169.7% | -1148.5% |
| 2023 | -$25M | -67.7% | -$26M | $-0.70 | -879.5% | -905.0% |
| 2022 | -$15M | -15.8% | -$15M | $-0.42 | -221.7% | -224.3% |
| 2021 | -$13M | -122.5% | -$13M | $-0.36 | - | - |
| 2020 | -$6M | +20.7% | -$6M | $-0.16 | -141.0% | -142.1% |
| 2019 | -$7M | - | -$7M | $-0.21 | - | - |
Download Data
Export HCWB earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
7+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
HCWB — Frequently Asked Questions
Quick answers to the most common questions about buying HCWB stock.
What is HCWB earnings per share (EPS)?
HCWB trailing twelve-month (TTM) diluted EPS is $-0.78, reflecting -1280.5% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2019 to 2025 is available in the table on this page.
What is HCW Biologics Inc.'s net income?
HCW Biologics Inc. (HCWB) trailing twelve-month net income is $-2M as of 2025. Earnings declined -1280.5% year-over-year.
Is HCWB profitable?
HCWB is not currently profitable on a TTM basis, reporting a net loss of $-2M. Net margin is -14677.1%. Investors should monitor for a return to profitability.
What is HCWB's earnings growth rate?
HCWB compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2019 to 2025.
What are HCWB's profit margins?
HCW Biologics Inc. net profit margin is -14677.1%, operating margin is -20757.6%, and gross margin is +20.0%. Below-average margins reflect competitive or cost pressures. Return on Equity is -287.9%.
Is HCWB growing earnings?
HCWB earnings are declining — EPS fell -1280.5% year-over-year. TTM net income dropped to $-2M. This contrasts with the 5-year CAGR of N/A.
What was HCWB's best earnings year?
HCW Biologics Inc.'s highest annual net income on record is $-6M, achieved in fiscal year 2020. Earnings history on this page spans 2019 to 2025 and includes all annual and quarterly figures.
What were HCWB's earnings last quarter?
HCWB's most recent reported quarter was Q1 2026. Net income was $4M with diluted EPS of $1.97. For a full breakdown of all quarters, see the quarterly earnings table on this page.